Full Text View
Tabular View
Study Results
Related Studies
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)
This study has been completed.
Study NCT00590044   Information provided by Emory University
First Received: December 28, 2007   Last Updated: May 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Ketoacidosis
Additional conditions recognized in this trial
Acidosis
More general conditions related to this trial
Acid-Base Imbalance
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
insulin glargine+ glulisine
NPH + Regular insulin
Additional drug interventions recognized in this trial
Glargine
Insulin
More general drug interventions related to this trial
Hypoglycemic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Emory University
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services